Article Versions Notes

Strachan DC, Gu CJ, Kita R, Anderson EK, Richardson MA, Yam G, Pimm G, Roselli J, Schweickert A, Terrell M, et al. Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML. Cancers. 2022; 14(24):6240. https://doi.org/10.3390/cancers14246240

Strachan, Debbie C., Christine J. Gu, Ryosuke Kita, Erica K. Anderson, Michelle A. Richardson, George Yam, Graham Pimm, Jordan Roselli, Alyssa Schweickert, Maci Terrell, and et al. 2022. "Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML" Cancers 14, no. 24: 6240. https://doi.org/10.3390/cancers14246240

Strachan, D. C., Gu, C. J., Kita, R., Anderson, E. K., Richardson, M. A., Yam, G., Pimm, G., Roselli, J., Schweickert, A., Terrell, M., Rashid, R., Gonzalez, A. K., Oviedo, H. H., Alozie, M. C., Ilangovan, T., Marcogliese, A. N., Tada, H., Santaguida, M. T., & Stevens, A. M. (2022). Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML. Cancers, 14(24), 6240. https://doi.org/10.3390/cancers14246240